EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention

Awad I Javaid iD, Joel E Michalek, Aleksandra B Gruslova iD, Serene A Hoskins, Chowdhury H Ahsan, Marc D Feldman

Catheterization and Cardiovascular Interventions · 2024-01 · 103 (1) · 30-41

DOI: 10.1002/ccd.30913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 23.11.2023. Verfasst von Awad I Javaid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Kirk Kerkorian School of Medicine at the University of Nevada Las Vegas, Las Vegas, Nevada, USA. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Myocardial Infarction, Heart-Assist Devices. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies have compared Impella use to intra‐aortic balloon pump (IABP) use in patients with acute myocardial infarction and cardiogenic shock (AMI‐CS) undergoing percutaneous coronary intervention (PCI). Our objective was to compare clinical outcomes in patients with AMI‐CS undergoing PCI who received Impella (percutaneous left ventricular assist device) without vasopressors, IABP without vasopressors, and vasopressors without mechanical circulatory support (MCS).

Methods

We queried the National Inpatient Sample (NIS) using ICD‐10 codes (2015–2018) to identify patients with AMI‐CS undergoing PCI. We created three propensity‐matched cohorts to examine clinical outcomes in patients receiving Impella versus IABP, Impella versus vasopressors without MCS, and IABP versus vasopressors without MCS.

Results

Among 17,762 patients, Impella use was associated with significantly higher in‐hospital major bleeding (31.4% vs. 13.6%; p < 0.001) and hospital charges ( p < 0.001) compared to IABP use, with no benefit in mortality (34.1% vs. 26.9%; p = 0.06). Impella use was associated with significantly higher mortality (42.3% vs. 35.7%; p = 0.02), major bleeding (33.9% vs. 22.7%; p = 0.001), and hospital charges ( p < 0.001), when compared to the use of vasopressors without MCS. There were no significant differences in clinical outcomes between IABP use and the use of vasopressor without MCS.

Conclusions

In this analysis of retrospective data of patients with AMI‐CS undergoing PCI, Impella use was associated with higher mortality, major bleeding, and in‐hospital charges when compared to vasopressor therapy without MCS. When compared to IABP use, Impella was associated with no mortality benefit, along with higher major bleeding events and in‐hospital charges. A vasopressor‐only strategy suggested no difference in clinical outcomes when compared to IABP. This study uses the NIS for the first time to highlight outcomes in AMI‐CS patients undergoing PCI when treated with vasopressor support without MCS, compared to Impella and IABP use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionMyocardial InfarctionHeart-Assist DevicesHumansShock, CardiogenicRetrospective StudiesTreatment OutcomeIntra-Aortic Balloon PumpingHemorrhage

Stichwörter der Autor:innen

ACS-acute coronary syndromeCS-cardiogenic shockImpellaMCS-mechanical circulatory supportPCI-percutaneous coronary intervention

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Kirk Kerkorian School of Medicine at the University of Nevada Las Vegas, Las Vegas, Nevada, USA.
  • Department of Population Health Sciences, The University of Texas Health at San Antonio, San Antonio, Texas, USA.
  • Division of Cardiology, Department of Medicine, The University of Texas Health at San Antonio, San Antonio, Texas, USA.

ORCID-Profile: Awad I Javaid, Aleksandra B Gruslova

Zitieren

APA

Javaid, A. I., Michalek, J. E., Gruslova, A. B., Hoskins, S. A., Ahsan, C. H., & Feldman, M. D. (2024). Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 103(1), 30-41. https://doi.org/10.1002/ccd.30913

Vancouver

Javaid AI, Michalek JE, Gruslova AB, Hoskins SA, Ahsan CH, Feldman MD. Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 2024;103(1):30-41. doi:10.1002/ccd.30913

BibTeX
@article{Javaid2024,
  author = {Javaid, Awad I and Michalek, Joel E and Gruslova, Aleksandra B and Hoskins, Serene A and Ahsan, Chowdhury H and Feldman, Marc D},
  title = {Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  volume = {103},
  number = {1},
  pages = {30--41},
  doi = {10.1002/ccd.30913}
}
Kostenlos starten →